Short description
We are a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.
Description
Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Boston, Massachusetts, United States, North America
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noaccess, Blurry Noaccess
Sign in for full access
Founders
Philip Austin